NASDAQ:NBRV
Delisted

Nabriva Therapeutics Ag Stock Signals

etoro logo Buy NBRV
*Your capital is at risk
$1.42
+0 (+0%)
At Close: Nov 24, 2023

Latest Data & Signals Issued

Below are some of the latest signals issued for Nabriva Therapeutics AG

General

Signal Type Signal Value Data
Score 0.000 80 days ( 0 %
Last Price $1.42 0 %
Performance History
7 Days
$1.42 $1.42
0%
30 Days
$1.42 $1.42
0%
12 Mos
$2.17 $1.42
-34.56%

5/18

Active Buy Signals

Specific Signals

Short Term
Net score: 54.73
Signal Type Signal Value Importance Data
High / Low N/A Very Low $1.42 - $1.42
Trend - 3 mos 4.39 % High Width: 78.75 %
Pred. range - 3 mos $0.85 - $1.52 Low -39.99 % - 7.27 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Sell Very Low Nov 22, 2023 - 2 days
RSI Short Pivot Signal Sell Very Low Sep 14, 2023 - 50 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Buy Medium Sep 13, 2023 - 51 days
Short/Long MA 3 mos Buy Medium Sep 13, 2023 - 51 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 40.16
Signal Type Signal Value Importance Data
Trend - 12 mos -22.55 % Very High Width: 306.14 %
Pred. range - 12 mos $0.366 - $1.49 High -74.21 % - 4.75 %
Short MA 12 mos Sell Very High Jul 24, 2023 - 87 days
Long MA 12 mos Buy Very High Nov 01, 2023 - 17 days
Short/Long MA 12 mos Buy Very High Nov 01, 2023 - 17 days
Pivot Long Sell Low Nov 22, 2023 - 2 days
RSI Long Pivot Signal Sell Low Sep 25, 2023 - 44 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT NABRIVA THERAPEUTICS AG
Nabriva Therapeutics AG
Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections. The company's product includes SIVEXTRO, an oxazolidinone-class antibacterial for the treatment of acute bacterial skin and skin structure infection (ABSSSI); and XENLETA, a semi-synthetic pleuromutilin antibiotic for the treatment of community-acquired bacterial pneumonia. It also dev...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE